Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The clinical oncology next generation sequencing market is forecasted to achieve notable growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 14%, as per The Business Research Company’s market report!

Read More On The Clinical Oncology Next Generation Sequencing Market Report 2022 – https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

The Clinical Oncology Next Generation Sequencing Market Size In 2022 And Forecast
The global clinical oncology next generation sequencing market is expected to grow from $0.36 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The clinical oncology next-generation sequencing market is expected to grow to $0.68 billion in 2026 at a CAGR of 14.7%.

The clinical oncology next-generation sequencing market consists of sales of devices and equipment used in clinical oncology next-generation sequencing and related services by entities (organizations, sole traders, and partnerships) that manufacture clinical oncology next-generation sequencing equipment.

Request for A Free Sample Of The Global Clinical Oncology Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

Rise In The Number Of Cancer Cases Is Driving The Growth Of The Clinical Oncology Next Generation Sequencing Market
According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the clinical oncology next-generation sequencing market.

Competitive Landscape And The Regional Analysis Of The Clinical Oncology Next Generation Sequencing Market
Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences.

Additionally, as per TBRC’s research – North America was the largest region in the clinical oncology next generation sequencing market in 2021 holding the largest market share.

The Clinical Oncology Next Generation Sequencing Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the clinical oncology next generation sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the clinical oncology next generation sequencing market.

Investing In Automation Of Workflow – A Key Trend In The Clinical Oncology Next Generation Sequencing Market
Companies in the clinical oncology next-generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample to sample variability.

Clinical Oncology Next Generation Sequencing Market Segmentation By The Business Research Company

1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

2) By Application: Screening, Companion Diagnostics, Other Diagnostics

3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories

Here Are Some Reports Related To The Clinical Oncology Next Generation Sequencing Market –

Oncology Molecular Diagnostics Global Market Report 2022

Interventional Oncology Devices Global Market Report 2022

Diagnostic Equipment Global Market Report 2022

Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Check out our:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model